HOYA FY2026 Pre-Tax Profit Surges 26% to ¥328bn; Dividend Nearly Doubled to ¥295

HOYA Corporation (TSE: 7741) — a global supplier of precision optics spanning two segments: Life Care (eyeglass and contact lenses, medical endoscopes and intraocular lenses) and Information Technology (semiconductor mask blanks, photomasks, HDD glass substrates and optical components) — reported record results on April 30, 2026 for the fiscal year ended March 2026, under IFRS. Revenue rose 9.4% year-on-year to ¥947,749 million, pre-tax profit jumped 26.0% to ¥327,668 million, and profit attributable to owners climbed 25.2% to ¥253,085 million, lifting EPS to ¥743.93 from ¥581.45.

Mask blanks and medical optics drive margin expansion

Profit grew far faster than revenue, with the pre-tax margin widening to 34.6% as HOYA's high-value franchises performed strongly. The company is the dominant global supplier of mask blanks used in EUV and advanced semiconductor lithography, a near-irreplaceable position that benefits from leading-edge chip investment; its Life Care segment pairs steady eyeglass-lens demand with growing medical-device sales. Return on equity reached 25.4%, and total comprehensive income surged 60.6% to ¥316,807 million.

Fortress balance sheet and sharply higher dividend

HOYA's balance sheet remained exceptionally strong, with total assets of ¥1,300,897 million, equity attributable to owners of ¥1,020,460 million and an equity ratio of 78.4% (book value per share ¥3,041.71). Operating cash flow was ¥278,446 million and cash and equivalents ended the year at ¥574,092 million. Reflecting the record result, the company raised its annual dividend to ¥295.00 per share (¥125 interim + ¥170 year-end) from ¥160.00 — a payout ratio of 39.7%.

Full-year guidance to follow later

In keeping with its long-standing practice, HOYA did not issue full-year FY2027 guidance with these results; the company discloses first-half guidance when it reports its first quarter (late July/early August) and full-year guidance at the third quarter. Investors will look to those updates for the outlook on semiconductor-materials demand and medical-device growth.

The combination of near-double-digit revenue growth, a 34.6% pre-tax margin and a 25.4% return on equity underscores HOYA's position as one of the most profitable large-cap manufacturers in Japan, with leadership in markets — EUV mask blanks, endoscopes, intraocular lenses — that carry high barriers to entry.

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.